Recent advances in antimalarial drug development

✍ Scribed by Suryanaryana Vangapandu; Meenakshi Jain; Kirandeep Kaur; Premanand Patil; Sanjay R. Patel; Rahul Jain

• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 452 KB
• Volume: 27
• Category: Article
• ISSN: 0198-6325
• DOI: 10.1002/med.20062

✦ Synopsis

Abstract

Malaria caused by protozoa of the genus Plasmodium, because of its prevalence, virulence, and drug resistance, is the most serious and widespread parasitic disease encountered by mankind. The inadequate armory of drugs in widespread use for the treatment of malaria, development of strains resistant to commonly used drugs such as chloroquine, and the lack of affordable new drugs are the limiting factors in the fight against malaria. These factors underscore the continuing need of research for new classes of antimalarial agents, and a re‐examination of the existing antimalarial drugs that may be effective against resistant strains. This review provides an in‐depth look at the most significant progress made during the past 10 years in antimalarial drug development. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 1, 65–107, 2007